Compare J M Smucker Co (SJM) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
J M Smucker Co vs Twist Bioscience Corp — how do they compare? J M Smucker Co trades at $112.69 (market cap $11.97B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: J M Smucker Co is far larger — about 2.2× Twist Bioscience Corp's market cap, and J M Smucker Co pays a 3.93% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| SJM | TWST | |
|---|---|---|
Market Cap | $11.97B | $5.45B |
Sector | Consumer Staples | Health |
52-Week High | $117.05 | $102.88 |
52-Week Low | $89.53 | $24.16 |
Enterprise Value | $19.00B | $5.37B |
Dividend Yield | 3.93% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About J M Smucker Co
J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
